Home › Trial NCT04824352
Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory Osteosarcoma
- Trial IDNCT04824352
- StatusSuspended
- PhasePhase 2
- Study typeInterventional
- SponsorPeking University People's Hospital
- Enrollment44
- Start date2021-04-01
- ConditionsEffect of Drug · Toxicity, Drug
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.